文献速递消化内镜

社区门诊手术中心内镜前症状筛查与普遍新型冠状病毒逆转录聚合酶链反应检测的结果

Outcomes of symptom screening and universal COVID-19 reverse transcriptase polymerase chain reaction testing before endoscopy in a community-based ambulatory surgery center.
PubMed 文献 · Gastrointest Endosc · 2020-10-08

研究回顾性分析2020年5月22日至6月28日在Rockford Gastroenterology Associates计划接受择期内镜的1000例患者,均完成ASGE COVID-19风险筛查问卷且RT-PCR检测结果有效。8例(0.80%)RT-PCR阳性,其中3例有症状;问卷阳性预测值2.46%、阴性预测值99.43%。结论认为仅凭症状筛查不应作为大流行期间选择内镜患者的主要术前评估工具。

要点

  • 1000例患者中8例(0.80%)COVID-19 RT-PCR阳性,其中3例报告至少1种症状。
  • ASGE COVID-19风险筛查问卷阳性预测值2.46%,阴性预测值99.43%。
  • RT-PCR阳性阻止了5例无症状患者接受内镜,119例有症状但RT-PCR阴性者得以接受内镜评估。

核心结论

  • 社区门诊手术中心COVID-19感染率低,RT-PCR阳性率为0.80%。
  • ASGE问卷无症状对RT-PCR阴性有高预测价值(阴性预测值99.43%),而有症状者阳性预测值低(2.46%)。
  • 仅凭症状筛查不应作为COVID-19大流行期间选择内镜患者的主要术前评估工具。

研究设计与样本

  • 回顾性收集2020年5月22日至6月28日在Rockford Gastroenterology Associates计划接受择期门诊内镜患者的病历资料。
  • 纳入1000例完成ASGE COVID-19风险筛查问卷临床部分且RT-PCR检测结果有效的患者。
  • 采用描述性统计和标准计算方法确定阳性和阴性预测值。

主要发现

  • 1000例患者中8例COVID-19 RT-PCR阳性,阳性率0.80%。
  • 8例阳性患者中3例在ASGE问卷报告1种或以上症状。
  • 另有119例在ASGE问卷报告症状但COVID-19检测阴性。
  • ASGE COVID-19风险筛查问卷阳性预测值为2.46%,阴性预测值为99.43%。

临床怎么用

  • RT-PCR阳性阻止了5例无症状患者接受内镜。
  • 119例有症状患者经RT-PCR检测后接受了内镜评估,若无RT-PCR检测这些患者将被排除。
  • 作者认为仅凭症状筛查不应作为COVID-19大流行期间选择内镜患者的主要术前评估工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Elective endoscopy resumed in our outpatient ambulatory center after instituting the preprocedure policy of a confirmed negative coronavirus disease 2019 (COVID-19) reverse transcriptase polymerase chain reaction (RT-PCR) status performed 72 hours before a scheduled procedure as mandated by the state of Illinois. In addition, all patients were required to contemporaneously complete the American Society for Gastrointestinal Endoscopy (ASGE) COVID-19 risk screening questionnaire published April 28, 2020 as outlined in the ASGE guidance document for reopening GI endoscopy during the COVID-19 pandemic. The aim of our study is to report the outcomes of 1000 patients who successfully completed the clinical aspects of the ASGE COVID-19 risk screening questionnaire and whose RT-PCR tests were valid for interpretation. METHODS: Data were retrospectively collected from patient medical records for demographics, symptom responses to the preprocedure ASGE COVID-19 risk screening questionnaire, and RT-PCR test results of patients scheduled to undergo an elective outpatient endoscopy at Rockford Gastroenterology Associates from May 22 through June 28, 2020. Descriptive statistics and standard calculation methods to determine both positive and negative predictive values were used for data analysis. RESULTS: Eight of 1000 patients included in the study tested positive for COVID-19. Three of 8 patients reported 1 or more symptoms on the ASGE COVID-19 risk screening questionnaire. One hundred nineteen additional patients reported symptoms on the ASGE COVID-19 risk screening questionnaire but tested negative for COVID-19. The positive and negative predictive values of the ASGE COVID-19 risk screening questionnaire were 2.46% and 99.43%, respectively. CONCLUSIONS: The low incidence of COVID-19 infection in a community-based ambulatory surgery center is supported by a positive RT-PCR test rate of .80%. Absence of symptoms on the ASGE COVID-19 risk screening questionnaire was highly predictive of a negative RT-PCR test (99.43% negative predictive value), whereas the positive predictive value was low (2.46%) in symptomatic patients. A positive RT-PCR test was invaluable in preventing 5 asymptomatic patients from undergoing endoscopy. Similarly, 119 symptomatic patients underwent endoscopic evaluation who would have otherwise been excluded without RT-PCR testing. Symptom-based screening alone should not be the primary preprocedural assessment tool in selecting patients for undergoing endoscopy during the COVID-19 pandemic.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bowyer B, Thukral C, Patel S, et al. Outcomes of symptom screening and universal COVID-19 reverse transcriptase polymerase chain reaction testing before endoscopy in a community-based ambulatory surgery center. Gastrointest Endosc. 2020. PMID: 33039400. doi:10.1016/j.gie.2020.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。